Cargando…
Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA)
Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) is an essential, highly conserved merozoite antigen that forms an important multi-protein complex (RH5/Ripr/CyRPA) necessary for erythrocyte invasion. CyRPA is a promising blood-stage vaccine target that has been shown to elicit potent s...
Autores principales: | Somanathan, Anjali, Mian, Syed Yusuf, Chaddha, Kritika, Uchoi, Seemalata, Bharti, Praveen K., Tandon, Ravi, Gaur, Deepak, Chauhan, Virander Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535676/ https://www.ncbi.nlm.nih.gov/pubmed/36211427 http://dx.doi.org/10.3389/fimmu.2022.1005332 |
Ejemplares similares
-
Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA
por: Favuzza, Paola, et al.
Publicado: (2016) -
Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA
por: Chen, Lin, et al.
Publicado: (2017) -
Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against Plasmodium falciparum CyRPA
por: Knudsen, Anne S., et al.
Publicado: (2021) -
The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
por: Ragotte, Robert J., et al.
Publicado: (2020) -
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations
por: Azasi, Yvonne, et al.
Publicado: (2020)